Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 85
Oncology Drugs 85
Optical 76
Optical Disorders Drugs 75
Immune Disorders Drugs 72
Cardiovascular Drugs 51
Musculoskeletal Disorders Drugs 40
Dermatological Drugs 38
Biopharmaceuticals 36
Biotechnology 31
Genomics 29
Clinical Trials 29
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Respiratory Drugs 17
Allergy and Immunology 16
Infusions and Injectables 14
Gastrointestinal Drugs 14
Allergy Drugs 14
Drugs by Therapeutic Area 13
Lung Cancer Drugs 11
Dermatology 10
Hematological Drugs 10
Oncology 10
Leukemia Drugs 9
Needles and Syringes 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Cardiovascular Devices 4
Drug Delivery 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

703 Results (Page 19 of 36)
- Relevance
  Sort by

Basal Cell Neoplasms - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1758EUR$2,000USD£1,515GBP

Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
104 Pages
Global

From

€1758EUR$2,000USD£1,515GBP

Multiple Myeloma Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
330 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

Glucagon-Like Peptide 1 Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
May 2022
365 Pages
Global

From

€4219EUR$4,799USD£3,636GBP

Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€6990EUR$7,950USD£6,023GBP

$Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image$

Refractory Multiple Myeloma- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2638EUR$3,000USD£2,273GBP

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
85 Pages
Global

From

€3077EUR$3,500USD£2,652GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1714EUR$1,950USD£1,477GBP

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€6990EUR$7,950USD£6,023GBP

Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€6990EUR$7,950USD£6,023GBP

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region

 Report
January 2025
768 Pages
Global

From

€4219EUR$4,799USD£3,636GBP

Non-small Cell Lung Cancer Drugs Market 2023-2027

 Report
May 2023
167 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021

 Clinical Trials
October 2021
121 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

Postpartum Depression Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
417 Pages
Global

From

€1758EUR$2,000USD£1,515GBP

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
4115 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
1834 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

703 Results (Page 19 of 36)
- 1
- 17
- 18
- 19
- 20
- 21

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.